Sophie Liekens1, Tim Smits, Gert Laekeman, Veerle Foulon. 1. Research Centre for Pharmaceutical Care and Pharmaco-economics, Katholieke Universiteit Leuven, Bus 521, Herestraat 49, 3000, Leuven, Belgium. sophie.liekens@pharm.kuleuven.be
Abstract
BACKGROUND: In the past three decades, the role of pharmacists has evolved toward working with other health professionals and the public in a patient-centered model of practice, which is called pharmaceutical care. This model has been implemented for most physical illnesses but in relation to mental health, pharmacists' role is still evolving. OBJECTIVE: The objective of this study was to evaluate pharmacists' attitudes, current practice, perceived barriers and training needs concerning pharmaceutical care for people with depression. SETTING: All pharmacists attending obligatory regional meetings of the Surplus Network (a Flemish community pharmacy chain) during April and May 2009. METHOD: Written survey consisting of questions on (1) pharmacists' attitude and current practice in depression care and pharmaceutical care for people with other illnesses; (2) potential barriers in providing pharmaceutical care for people with depression; and (3) training needs. Paired samples T tests and Wilcoxon-tests were used to analyze the data. MAIN OUTCOME MEASURE: Attitude and current practice in depression care versus care for other illnesses. RESULTS: Although the results show no difference in the attitude of pharmacists toward providing care for people with depression versus other illnesses (p = 0.315), pharmacists report to provide significantly less care to people with depression compared to people with other illnesses (p < 0.05). Perceived barriers toward providing depression care were the lack of information about the person and their treatment, the fact that depression is a difficult condition, the lack of education in mental health and the lack of time and privacy in the pharmacy. These, and the reported training needs, may limit the self-efficacy of pharmacists and hence influence current practice. CONCLUSION: In spite of pharmacists' positive attitude toward depression care, current practice displays actionable flaws. Barriers and training needs should be addressed in order to improve pharmaceutical care for people with depression.
BACKGROUND: In the past three decades, the role of pharmacists has evolved toward working with other health professionals and the public in a patient-centered model of practice, which is called pharmaceutical care. This model has been implemented for most physical illnesses but in relation to mental health, pharmacists' role is still evolving. OBJECTIVE: The objective of this study was to evaluate pharmacists' attitudes, current practice, perceived barriers and training needs concerning pharmaceutical care for people with depression. SETTING: All pharmacists attending obligatory regional meetings of the Surplus Network (a Flemish community pharmacy chain) during April and May 2009. METHOD: Written survey consisting of questions on (1) pharmacists' attitude and current practice in depression care and pharmaceutical care for people with other illnesses; (2) potential barriers in providing pharmaceutical care for people with depression; and (3) training needs. Paired samples T tests and Wilcoxon-tests were used to analyze the data. MAIN OUTCOME MEASURE: Attitude and current practice in depression care versus care for other illnesses. RESULTS: Although the results show no difference in the attitude of pharmacists toward providing care for people with depression versus other illnesses (p = 0.315), pharmacists report to provide significantly less care to people with depression compared to people with other illnesses (p < 0.05). Perceived barriers toward providing depression care were the lack of information about the person and their treatment, the fact that depression is a difficult condition, the lack of education in mental health and the lack of time and privacy in the pharmacy. These, and the reported training needs, may limit the self-efficacy of pharmacists and hence influence current practice. CONCLUSION: In spite of pharmacists' positive attitude toward depression care, current practice displays actionable flaws. Barriers and training needs should be addressed in order to improve pharmaceutical care for people with depression.
Authors: Kam L Capoccia; Denise M Boudreau; David K Blough; Allan J Ellsworth; Dave R Clark; Nancy G Stevens; Wayne J Katon; Sean D Sullivan Journal: Am J Health Syst Pharm Date: 2004-02-15 Impact factor: 2.637
Authors: S Elina Aaltonen; Niina P Laine; Daisy Volmer; Manjiri S Gharat; Ruta Muceniece; Anna Vitola; Veerle Foulon; Franciska A Desplenter; Marja S Airaksinen; Timothy F Chen; J Simon Bell Journal: Pharm Pract (Granada) Date: 2010-03-15